Evidence map›Paper›PMID 37400432›Full record

Trial reportTranslational psychiatry2023

Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial.

Jean-Marie Batail, Xiaoqian Xiao, Azeezat Azeez, Claudia Tischler, Ian H Kratter, James H Bishop, Manish Saggar, Nolan R Williams

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03068715 nacompletednot on this map

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)

TypeinterventionalSponsorStanford UniversityRan2017 to 2021Enrolled30ConditionsTreatment Resistant DepressionArmsActive TBS-DLPFC, Sham TBS-DLPFC, Open label TBS-DLPFC
NCT07684911 recruitingnot on this mapstarted 2026, after this paper: background citation

Longitudinal Study on the Sustainability of Transcranial Magnetic Stimulation Protocols - Biomarkers

TypeobservationalSponsorHospital Center Guillaume RégnierRan2026 to 2029Enrolled30ConditionsDepression - Major Depressive Disorder, Depression Bipolar, Depression UnipolarArmsRepetitive transcranial magnetic stimulation
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Non-inferiority of Accelerated vs. Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder: A Systematic Review.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jean-Marie Batail *Stanford Brain Stimulation Lab, Stanford, CA, USA.
Xiaoqian Xiao *Stanford Brain Stimulation Lab, Stanford, CA, USA.
Azeezat Azeez *Stanford Brain Stimulation Lab, Stanford, CA, USA.
Claudia TischlerBaylor College of Medicine, Houston, TX, USA.
Ian H KratterStanford Brain Stimulation Lab, Stanford, CA, USA.ORCID 0000-0001-9122-4525
James H BishopStanford Brain Stimulation Lab, Stanford, CA, USA.
Manish Saggar *Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.ORCID 0000-0002-5307-2249
Nolan R Williams *Stanford Brain Stimulation Lab, Stanford, CA, USA. nolanw@stanford.edu.ORCID 0000-0003-4368-3203
Stanford Medicine · USBaylor College of Medicine · USStanford Health Care · USStanford University · US

Funding

Only time will tell: a computational psychiatry approach to model temporal transitions in brain activity as a lens towards developing better diagnostic nosology for psychiatric illnessDP2MH119735 · NIMH · STANFORD UNIVERSITY · PI SAGGAR, MANISH · 2018 to 2018
$2.4M
NIMH NIH HHS DP2 MH119735
6 · The paper itself

Abstract

Here, we investigated the brain functional connectivity (FC) changes following a novel accelerated theta burst stimulation protocol known as Stanford Neuromodulation Therapy (SNT) which demonstrated significant antidepressant efficacy in treatment-resistant depression (TRD). In a sample of 24 patients (12 active and 12 sham), active stimulation was associated with significant pre- and post-treatment modulation of three FC pairs, involving the default mode network (DMN), amygdala, salience network (SN) and striatum. The most robust finding was the SNT effect on amygdala-DMN FC (group*time interaction F(1,22) = 14.89, p < 0.001). This FC change correlated with improvement in depressive symptoms (rho (Spearman) = -0.45, df = 22, p = 0.026). The post-treatment FC pattern showed a change in the direction of the healthy control group and was sustained at the one-month follow-up. These results are consistent with amygdala-DMN connectivity dysfunction as an underlying mechanism of TRD and bring us closer to the goal of developing imaging biomarkers for TMS treatment optimization.Trial registration: ClinicalTrials.gov NCT03068715.

Indexed as

Depressive Disorder, Treatment-ResistantMajor Depressive DisorderBrainBrain MappingHumansMagnetic Resonance Imaging

Identifiers

PMID37400432
PMCPMC10318050
OpenAlexW4382931297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.